Anti-Phospholamban antibody
产品特性
| Product Cat#: | AB-06-3511 |
| Product type: | Primary antibody |
| Antigen: | Phospholamban |
| Immunogen: | Peptide |
| Species immunized: | Mouse |
| Isotype: | IgG1 |
| Applications: | Western Blot (1:90-1:1000); Immunoprecipitation (1-2 μg per 100-500 μg of total protein(1 ml of cell lysate)); Immunofluorescence (1:40-1:500) |
| Reactivity: | Human,mouse,rat |
| Clonality (clone number): | Monoclonal (1G3) |
| Form: | Liquid |
| Buffer: | Tris-HCl buffer (pH7.4), 1% BSA;40% glycerol, 0.05% NaN3. |
| Concentration: | 1 mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | Cardiac phospholamban antibody |
| CMD1P antibody | |
| CMH18 antibody | |
| PLB antibody | |
| Pln antibody | |
| PPLA_HUMAN antibody |
展开
靶标信息
eversibly inhibits the activity of ATP2A2 in cardiac sarcoplasmic reticulum by decreasing the apparent affinity of the ATPase for Ca2+. Modulates the contractility of the heart muscle in response to physiological stimuli via its effects on ATP2A2. Modulates calcium re-uptake during muscle relaxation and plays an important role in calcium homeostasis in the heart muscle. The degree of ATP2A2 inhibition depends on the oligomeric state of PLN. ATP2A2 inhibition is alleviated by PLN phosphorylation.
产品来源
洱泮科技实验室
